The radiation therapy sector promotes the value of radiation therapy to improve access to its lifesaving technologies. Radiation therapy, also known as radiotherapy, is a cutting-edge cancer treatment that uses beams of high energy to kill, shrink, or control the growth of tumors.
AdvaMed represents all major radiation therapy manufacturers in the U.S. and abroad. The radiation therapy sector seeks to advance policies that promote innovation and increase access to radiation therapy technologies. Radiation therapy contributes to the long-term survival of millions of cancer patients around the world.
Radiation therapy is a safe and effective cancer treatment.
Approximately 50%-60% of all people diagnosed with cancer receive radiation therapy at some point during their care. If every cancer patient who needs radiation therapy had access to it, estimates show that more than 1 million more lives would be saved every year.
Radiation therapy is curative.
Radiation therapy can help manage breast, lung, prostate, colorectal, head and neck, and cervical cancer, which account for more than 50% of cancer cases worldwide. It can be used alone or in combination with other treatments, like chemotherapy, immunotherapy, and surgery.
Radiation therapy is cost-effective.
When stereotactic radiotherapy and stereotactic body radiation therapy are used to treat brain, spine, lung, prostate and pancreatic cancers, treatment outcomes were comparable and even superior to other treatment options while simultaneously saving the patients and providers money. In addition to curing cancer, radiation therapy is also used for palliative care.